SCOTTS MIRACLE-GRO CO financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data SCOTTS MIRACLE-GRO CO files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	2,506	2,642	2,663	3,156	4,132	4,925	3,924	3,551	3,553	3,413
Cost of revenue	1,600	1,670	1,778	2,131	2,769	3,431	2,891	2,708	2,619	2,349
Gross profit	900	973	865	1,020	1,347	1,469	873	657	851	1,044
Research and development	36	39.9	42.5	39.6	39.7	45.4	45.3	35.7	34.6	34.8
Selling, general and administrative	518	551	540	601	758	744	613	551	559	603
Operating income	448	433	199	410	585	723	-434	-174	209	359
Interest expense	62.9	76.1	86.4	102	79.6	78.9	118	178	159	129
Interest income	3.9	10	0
Other non-operating income	0	-13.4	-1.7	271	20.1	18.6	6.9	0.3	-5.5	-5.3
Pre-tax income	384	315	116	582	511	677	-558	-453	-23.6	222
Income tax	138	117	-11.9	145	124	160	-121	-73.2	11.3	76.5
Income from continuing operations	247	198	128	437	386	516	-438	-380
Net income to minority interests	-0.5	0.5	0	-0.5	1.2	0.9	0	0
Net income	315	218	63.7	461	387	513	-438	-380	-34.9	145
EBITDA	510	507	282	499	680	817	-329	-81.9	289	421
EPS, basic	5.16	3.68	1.13	8.30	6.96	9.20	-7.88	-6.79	-0.61	2.52
EPS, diluted	5.09	3.63	1.12	8.18	6.81	8.96	-7.88	-6.79	-0.61	2.47
Shares, basic (weighted)	61.1	59.4	56.2	55.5	55.7	55.7	55.5	56	56.8	57.6
Shares, diluted (weighted)	62	60.2	57.1	56.3	56.9	57.2	55.5	56	56.8	58.7
Dividend per share	1.91	2.03	2.14	2.23	7.36	2.52	2.64	2.64	2.64	2.64

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	28.6	121	33.9	18.8	16.6	244	86.8	31.9	71.6	32.8
Receivables	127	198	226	224	475	483	299	304	177	161
Inventory	395	408	481	540	622	1,127	1,344	880	588	543
Other current assets	42.5	67.1	59.9	59	81	170	173	181	145	119
Total current assets	1,033	882	886	1,042	1,217	2,024	1,982	1,398	980	940
Property, plant and equipment	445	468	531	546	560	622	606	610	610	608
Lease right-of-use assets				0	156	293	289	263	265	244
Goodwill	372	442	543	539	544	605	254	244	244	244
Intangible assets	690	749	857	708	679	710	580	437	419	352
Other non-current assets	115	176	202	195	381	632	681	633	574	453
Total assets	2,756	2,747	3,055	3,029	3,381	4,800	4,297	3,414	2,872	2,742
Accounts payable	131	153	151	214	391	609	423	271	255	221
Accrued liabilities	59.9	55.9	39.2	73.2	145	91.5	44.2	51.2	72	93.5
Short-term debt	185	143	133	128	66.4	57.8	144	52.3	52.6	57.2
Total current liabilities	707	545	613	621	950	1,140	964	774	750	740
Long-term debt	1,031	1,258	1,884	1,524	1,455	2,237	2,826	2,557	2,174	2,049
Lease liabilities				0	113	234	223	220	216	193
Other non-current liabilities	284	261	177	162	272	410	359	350	338	301
Total liabilities	2,022	2,085	2,695	2,306	2,678	3,787	4,149	3,681	3,263	3,100
Total debt	1,222	1,410	2,026	1,634	1,495	2,282	2,963	2,614	2,225	2,105
Paid-in capital	402	408	420	442	483	477	364	353	362	352
Retained earnings	882	978	920	1,275	1,236	1,605	1,020	491	304	295
Treasury stock	-451	-668	-940	-904	-922	-1,002	-1,092	-999	-949	-894
Other comprehensive income	-117	-69.2	-46	-93.9	-99.1	-66.4	-145	-113	-107	-110
Shareholders' equity	715	649	355	719	697	1,013		-267	-391	-358
Minority interests	19.1	12.9	5	4.5	5.7	0
Total equity	734	662	360	723	703	1,013	148	-267	-391	-358
Total liabilities and equity	2,756	2,747	3,055	3,029	3,381	4,800	4,297	3,414	2,872	2,742
Shares outstanding	60.3	58.1	55.3	55.8	55.8	55.6	55.5	56.5	57.1	57.8

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	315	219	63.7	460	389	513	-438	-380	-34.9	145
Depreciation and amortization	62.3	73.8	83.4	89.3	94.7	93.8	105	92.5	80.6	62.7
Stock-based compensation	15.6	25.2	40.4	38.4	57.9	40.6	34.3	68.9	80.4	69
Deferred income tax	83.6	-17.4	-87.6	-33.3	-11.1	22.5	-183	-58.7	9.3	70.8
Change in receivables	-29.8	48.6	-2.7	0.6	-188	15.5	103	77.7	128	-16.6
Change in inventory	-29.4	3.6	14.3	-65	-80.6	-497	-204	451	294	-17.9
Change in payables	-45.3	9	-3.9	54.3	172	203	-171	-154	-1.6	-0.3
Cash from operations	244	363	343	227	558	272	-129	531	668	371
Capital expenditures	-58.3	-69.6	-68.2	-42.4	-62.7	-107	-114	-92.8	-84	-97.4
Acquisitions	-158	-122	-493	-6.6	0	-128	-237	0	0	-2.5
Purchases of investments				0	0	-193	-25	0	0
Cash from investing	-134	22.4	-581	255	46.9	-539	-283	-65.7	-100	-112
Debt issued	400	250	0	0	450
Debt repaid	-200	0	0	0	-400
Stock issued	14.7	11	10.5	21.4	17.6	15.2	3.3	2.3	3.8	11.9
Share buybacks	-137	-255	-328	-3.1	-53.2	-129	-258	-9.3	-5.1	-18.4
Dividends paid	-117	-120	-120	-125	-411	-143	-166	-149	-151	-154
Cash from financing	-129	-317	151	-497	-607	494	255	-520	-528	-294
Exchange rate effect	-2.1	1.6	0.4	-0.6	0	0.6	-0.4	-0.1	0.5	-0.2
Net change in cash	-21.3	70.4	-86.6	-15.1	-2.2	228	-157	-54.9	39.7	-35
Free cash flow	186	294	274	184	495	165	-243	438	584	274
Interest paid	54.1	69.8	81.6	93.5	75.9	61.6	113	174	158	131
Income taxes paid	80.9	112	-56.3	166	124	180	27.2	-18.2	9.4	12.9

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 27, 2026; growth uses fiscal years. Valuation uses the share price of $50.89 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	31.7%	Gross profit / revenue.
Operating margin	11.0%	Operating income / revenue.
EBITDA margin	12.8%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	7.2%	Pre-tax income / revenue.
Net margin	2.1%	Net income / revenue.
FCF margin	7.6%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	10.6%	Cash from operations / revenue.
Effective tax rate	37.9%	Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)	2.3%	Net income / average total assets.
Return on invested capital (ROIC)	12.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	17.7%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.4%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	3.0%	Capital expenditures / revenue.
D&A / revenue	1.8%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-3.9%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-4.5%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-3.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	22.8%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	6.2%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-5.0%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	71.7%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 5y	-9.3%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	45.6%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 5y	-9.1%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income CAGR, 5y	-17.8%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS CAGR, 5y	-18.4%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-44.4%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 5y	-7.8%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-53.1%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	-11.2%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	0.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	-18.5%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-4.5%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-13.9%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-4.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	3.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	1.9%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.6%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.21x	Current assets / current liabilities.
Quick ratio	0.67x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.02x	(Cash + short-term investments) / current liabilities.
Debt / assets	66.7%	Total debt / total assets.
Liabilities / assets	106.6%	Total liabilities / total assets.
Net debt	$2.09B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	4.69x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	3.38x	Operating income / interest expense.
Working capital	$238.3M	Current assets - current liabilities.
Goodwill and intangibles / assets	18.8%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$802.7M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.10x	Revenue / average total assets.
Fixed asset turnover	5.48x	Revenue / average property, plant and equipment.
Inventory turnover	4.91x	Cost of revenue / average inventory.
Days inventory	74 days	365 x average inventory / cost of revenue.
Receivables turnover	4.89x	Revenue / average receivables.
Days sales outstanding	75 days	365 x average receivables / revenue.
Days payables	48 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	101 days	Days inventory + days sales outstanding - days payables.
FCF conversion	356.3%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	28.7%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1.25	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$58.84	Revenue / diluted weighted shares.
FCF per share	$4.45	Free cash flow / diluted weighted shares.
Operating cash flow per share	$6.24	Cash from operations / diluted weighted shares.
Book value per share	-$3.59	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$13.79	Tangible book value / shares outstanding.
Cash per share	$0.48	(Cash + short-term investments) / shares outstanding.
Payout ratio	208.9%	Dividends paid / net income, when net income is positive.
Dividends / FCF	58.6%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	4.6%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$2.96B	Share price x shares outstanding.
Enterprise value	$5.05B	Market cap + total debt - cash - short-term investments.
P/E	40.1x	Market cap / net income. Only when net income is positive.
P/S	0.85x	Market cap / revenue.
P/FCF	11.3x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	8.02x	Market cap / cash from operations, when positive.
EV/Sales	1.45x	Enterprise value / revenue.
EV/EBIT	13.2x	Enterprise value / operating income, when both are positive.
EV/EBITDA	11.3x	Enterprise value / EBITDA, when both are positive.
EV/FCF	19.2x	Enterprise value / free cash flow, when both are positive.
FCF yield	8.9%	Free cash flow / market cap.
Earnings yield	2.5%	Net income / market cap (the inverse of P/E).
Dividend yield	5.2%	Dividends paid over the period / market cap.
Shareholder yield	5.6%	(Dividends paid + share buybacks) / market cap.

What was SCOTTS MIRACLE-GRO CO's revenue in fiscal 2025?

SCOTTS MIRACLE-GRO CO reported revenue of $3.41B for fiscal 2025, 3.9% lower than the year before.

Was SCOTTS MIRACLE-GRO CO profitable in fiscal 2025?

Yes. Net income was $145.2M, a net margin of 4.3%.

How much free cash flow did SCOTTS MIRACLE-GRO CO generate in fiscal 2025?

Cash from operations of $371.3M minus capital expenditures of $97.4M left free cash flow of $273.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to SCOTTS MIRACLE-GRO CO